Evidence map›Paper›PMID 40295016›Full record

ArticleIn vivo (Athens, Greece)

Evaluation of the Setup Accuracy of a Skin-markerless Positioning Using Surface-guided Radiotherapy in Accelerated Partial Breast Irradiation.

Ryohei Yamauchi, Fumihiro Tomita, Tomoyuki Masuda, Shinobu Akiyama, Nobue Uchida, Satoshi Ishikura

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryohei YamauchiDepartment of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan yamauchi.ryouhei@gmail.com.
Fumihiro TomitaDepartment of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan.
Tomoyuki MasudaDepartment of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan.
Shinobu AkiyamaDepartment of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan.
Nobue UchidaDepartment of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan.
Satoshi IshikuraDepartment of Radiation Oncology, St. Luke's International Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimAccelerated partial breast irradiation (APBI) is an alternative to whole-breast irradiation in early-stage breast cancer. This study evaluated the setup accuracy of a workflow without skin markers that uses surface-guided radiotherapy (SGRT) in conjunction with clip-based alignment in patients undergoing APBI. PATIENTS AND

methodsThis study recruited 35 patients who underwent APBI after breast-conserving surgery. Treatment plans were generated with 30 Gy in five fractions. During the treatment period, patients were positioned using AlignRT, intentionally omitting the skin marks. After the initial setup, the position was verified

resultsA total of 175 treatment fractions were analyzed. The mean±standard deviation (SD) residual setup error detected

conclusionThe integration of surface-guided radiation therapy and clip alignment effectively achieved accurate and efficient patient positioning; this can serve as an alternative to traditional skin markers in the external beam APBI workflow.

Indexed as

Breast NeoplasmsPatient PositioningRadiotherapy, Image-GuidedRadiotherapy Planning, Computer-AssistedAdultAgedCone-Beam Computed TomographyFemaleHumansMastectomy, SegmentalMiddle AgedRadiotherapy DosageSkinaccelerated partial breast irradiationBreast cancerintensity modulated radiation therapysurface-guided radiotherapy

Identifiers

PMID40295016
PMCPMC12041973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.